Clinical Trials Directory

Trials / Terminated

TerminatedNCT02213341

Impact of Vaccination on Th2 Immunity in Infancy

Status
Terminated
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
5 Months – 7 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the responses in the immune system of infants after they receive the vaccine against diphtheria, tetanus, and pertussis (DTaP). The investigators will do this by studying the immune cells and allergy responses in the blood prior to and after receipt of the third DTaP vaccine.

Detailed description

This is a single-site study of infants who are scheduled to receive their third series (\~6 month) vaccinations, as routine care, to investigate whether the diphtheria, tetanus, and pertussis (DTaP) vaccination has an effect on specific immunoglobulin E (IgE) levels to milk, egg, or peanut. Infants will be assigned to one of two groups depending on the infant's sensitization to milk, egg, and peanut.

Conditions

Interventions

TypeNameDescription
PROCEDURESkin prick allergen testTo test for hypersensitivity to milk, egg, or peanut
PROCEDUREBlood draw

Timeline

Start date
2015-01-01
Primary completion
2016-06-14
Completion
2016-06-14
First posted
2014-08-11
Last updated
2019-07-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02213341. Inclusion in this directory is not an endorsement.